Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Scalable Fabrication of Metallopolymeric Superstructures for Highly Efficient Removal of Methylene Blue.

Zhou M, Yang T, Hu W, He X, Xie J, Wang P, Jia K, Liu X.

Nanomaterials (Basel). 2019 Jul 11;9(7). pii: E1001. doi: 10.3390/nano9071001.

2.
3.

Hepatocyte growth factor induces breast cancer cell invasion via the PI3K/Akt and p38 MAPK signaling pathways to up-regulate the expression of COX2.

Kuang W, Deng Q, Deng C, Li W, Shu S, Zhou M.

Am J Transl Res. 2017 Aug 15;9(8):3816-3826. eCollection 2017.

4.

The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis.

Chen X, He C, Han D, Zhou M, Wang Q, Tian J, Li L, Xu F, Zhou E, Yang K.

Future Oncol. 2017 Apr;13(9):843-857. doi: 10.2217/fon-2016-0420. Epub 2017 Jan 11. Review.

PMID:
28075166
5.

RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.

Zou Q, Wu H, Fu F, Yi W, Pei L, Zhou M.

Arch Biochem Biophys. 2016 Nov 15;610:25-32. doi: 10.1016/j.abb.2016.09.007. Epub 2016 Sep 17.

PMID:
27651238
6.

Association of XPC polymorphisms with breast cancer risk.

Xu F, Zhong D, Tang Z, Zhou M, Zhu Y.

Breast Cancer Res Treat. 2011 Sep;129(2):655-7. doi: 10.1007/s10549-011-1550-y. Epub 2011 May 8. No abstract available.

PMID:
21553296

Supplemental Content

Loading ...
Support Center